NASDAQ: NEUP
Neuphoria Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for NEUP

Based on 1 analyst offering 12 month price targets for Neuphoria Therapeutics Inc

Min Forecast
$7.00+51.84%
Avg Forecast
$7.00+51.84%
Max Forecast
$7.00+51.84%

Should I buy or sell NEUP stock?

Based on 1 analyst offering ratings for Neuphoria Therapeutics Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NEUP stock forecasts and price targets.

NEUP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-05

1 of 1

NEUP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NEUP$4.61$7.00+51.84%Buy
ENLV$1.02$13.00+1,174.51%Strong Buy
SNTI$0.92$10.33+1,023.15%Strong Buy
VTGN$0.61$0.90+47.78%Hold
BRNS$0.63$4.00+534.92%Buy

Neuphoria Therapeutics Stock Forecast FAQ

Is Neuphoria Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: NEUP) stock is to Buy NEUP stock.

Out of 1 analyst, 0 (0%) are recommending NEUP as a Strong Buy, 1 (100%) are recommending NEUP as a Buy, 0 (0%) are recommending NEUP as a Hold, 0 (0%) are recommending NEUP as a Sell, and 0 (0%) are recommending NEUP as a Strong Sell.

If you're new to stock investing, here's how to buy Neuphoria Therapeutics stock.

What is NEUP's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NEUP price target, the average NEUP price target is $7.00, with the highest NEUP stock price forecast at $7.00 and the lowest NEUP stock price forecast at $7.00.

The Wall Street analyst predicted that Neuphoria Therapeutics's share price could reach $7.00 by Dec 5, 2026. The average Neuphoria Therapeutics stock price prediction forecasts a potential upside of 51.84% from the current NEUP share price of $4.61.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.